|
Market Closed -
OTC Markets
20:56:30 15/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0333 USD | +11.00% |
|
+18.93% | +28.08% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 8.83M | - | - | - | - | - |
| 1,116B | |||||
| 610B | |||||
| 501B | |||||
| 358B | |||||
| 366B |
Select your edition
All financial news and data tailored to specific country editions
